Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Histologically or cytologically confirmed advanced metastatic or unresectable advanced colorectal cancer (CRC) or gastric cancer that is relapsed, refractory, or progressive after:
CRC: at least 2 prior systemic regimens in the metastatic setting, and as appropriate in patients whose tumors are microsatellite instability-high (MSI-H), pembrolizumab as well.
Gastric cancer (including gastric and EGJ cancers): at least 2 prior systemic regimens in adjuvant, advanced, or metastatic setting and, as appropriate, a human epidermal growth factor receptor 2 (HER2) targeted agent.
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Adequate hematologic, hepatic, and renal function.
You may not be if
Any significant medical condition that, in the opinion of the investigator or sponsor, may place the participant at undue risk from the study.
Has electrocardiogram (ECG) abnormalities that make QT interval corrected (QTc) evaluation difficult.
Prior exposure to a pyrrolobenzodiazepine or indolinobenzodiazepine based drug.
Clareo Health | A Study of SC-007 in Subjects With Advanced Cancer
